PRESS RELEASE
Siena, April 18, 2025 – A common platform for the exchange of expertise and the creation of synergies in the biomedical research sector. This is the main focus of the agreement between Fondazione Toscana Life Sciences, a non-profit organization that aims to enhance and support research in the life sciences field, and Bios-Therapy, Physiological Systems for Health SpA, a leading company in the study and evaluation of natural products with cutting-edge technologies.
The goal of the alliance is to create a model of collaboration in the scientific field between the two entities, united by their interest in innovation and an approach based on sustainability and responsibility in decision-making for the benefit of the community. The next steps involve identifying specific areas and actions to promote the exchange of expertise, tools, and technological platforms.
“Our mission is to meet the demand for health with innovative natural products that meet the most rigorous scientific criteria of efficacy and safety, and we do so with a systemic approach, considering the organism as a whole” – states Valentino Mercati, founder of Bios-Therapy and Aboca – “As a benefit corporation, we pursue the goals of common benefit, and for this reason, we believe that collaboration with TSL represents a great growth opportunity for our respective entities and for the broader community of patients and citizens.”
“The agreement between TLS and Bios-Therapy lays the foundation for the creation of a strategic alliance for the future development of technologically advanced research projects and services in the life sciences sector – comments Andrea Paolini, General Director of the Fondazione Toscana Life Sciences – A collaboration, in line with the mission and objectives of TLS, that strengthens our role in supporting the main entities and excellences in the health sector, promoting an integrated and synergistic system of dialogue, capable of fostering public-private partnerships in the life sciences sector.”
